You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Human IL-17RE [orb2992793]Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 62.8 KDa. Observed: 63-88 KDa, reducing conditions
100 μg, 20 μg- Mouse IL-17RA [orb2993022]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 60.5 KDa. Observed: 70-110 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-17RE [orb2993034]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 61 KDa. Observed: 60-75 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IL-17RE [orb2993035]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.6 KDa. Observed: 38-42 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-17RB [orb2993036]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.8 KDa. Observed: 65-75 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Mouse IL-17RB [orb2993037]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.6 KDa. Observed: 38-45 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-17RD [orb2993045]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.9 KDa. Observed: 75-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-17RD [orb2993050]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.9 KDa. Observed: 45-65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Featured
Active
Item 1 of 1Human IL17 protein (Active) [orb358981]FeaturedActive> 95% as determined by SDS-PAGE and HPLC.
15.1 kDa
E.Coli
5 μg, 100 μg, 500 μg - FeaturedActiveItem 1 of 1Mouse Il17a protein [orb594832]FeaturedActive
Greater than 95% as determined by SDS-PAGE.
16.2 kDa
Mammalian cell
1 mg, 500 μg, 10 μg, 50 μg
